Date published: 2026-5-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

FBXO29 Activators

FBXO29 activators encompass a distinct class of chemical compounds that specifically enhance the functional activity of the FBXO29 protein through targeted biochemical mechanisms. These activators function by modulating the pathways in which FBXO29 is a critical component, leading to an upregulation of its activity without altering the protein's expression levels. FBXO29, being part of the F-box protein family, plays a significant role in the ubiquitin-proteasome system, contributing to the specificity of substrate recognition for ubiquitination and subsequent proteasomal degradation. The activators of FBXO29 are intricately designed to interact with the protein's substrate-binding domain, thereby facilitating the ubiquitination process of target proteins. This interaction enhances FBXO29's native function, which is pivotal for maintaining cellular protein homeostasis. By stabilizing the FBXO29-substrate complex, these activators indirectly influence various cellular pathways, including the cell cycle, apoptosis, and signal transduction, all of which are processes that FBXO29 is known to regulate through targeted protein degradation.

The efficacy of FBXO29 activators is found in their ability to interact with the protein's nuanced molecular structure, ensuring that FBXO29 retains its functional conformation and affinity for substrates. These activators may work by binding to allosteric sites on the FBXO29 protein, thereby inducing a conformational change that increases the protein's activity. Alternatively, some activators could enhance the interaction between FBXO29 and its E3 ligase complex partners, promoting a more efficient ubiquitination process. The specificity of these compounds is critical, as they do not broadly activate the ubiquitin-proteasome system but selectively enhance the function of FBXO29. Through this specificity, FBXO29 activators ensure that only the intended substrates are marked for degradation, thus upholding the precision of cellular regulatory mechanisms. The enhanced activity of FBXO29 through these activators underscores the importance of post-translational modifications in controlling the fate of cellular proteins, embodying the nuanced regulation of protein function that is essential for cellular health and homeostasis.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Lithium Chloride, by inhibiting GSK-3, prevents the phosphorylation of substrates that could be targeted by FBXO29 for ubiquitination, thereby indirectly enhancing FBXO29's stability and functional activity.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

MG132 is a proteasome inhibitor that by preventing the degradation of ubiquitinated proteins, indirectly increases the availability of proteins that may be substrates for FBXO29, enhancing its role in protein turnover.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$137.00
$219.00
$449.00
$506.00
19
(2)

Epoxomicin is a selective proteasome inhibitor which by stabilizing proteins that are potential substrates for FBXO29, could enhance the ubiquitination activity of FBXO29.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

Lactacystin is another proteasome inhibitor that prevents the degradation of polyubiquitinated proteins, thereby potentially increasing substrate availability for FBXO29-mediated ubiquitination processes.

Roscovitine

186692-46-6sc-24002
sc-24002A
1 mg
5 mg
$94.00
$265.00
42
(2)

Roscovitine, a cyclin-dependent kinase inhibitor, may stabilize proteins that are otherwise targeted for degradation, thereby increasing the functional activity of FBXO29 in the ubiquitination pathway.

MLN 4924

905579-51-3sc-484814
1 mg
$286.00
1
(0)

MLN4924 inhibits the NEDD8-activating enzyme, which is essential for the neddylation of cullin proteins that regulate SCF (Skp1-Cul1-F-box) complex function, thereby potentially enhancing FBXO29 activity within the SCF complex.

Ubiquitin E1 Inhibitor, PYR-41

418805-02-4sc-358737
25 mg
$360.00
4
(1)

PYR-41 is an inhibitor of ubiquitin-activating enzyme E1, leading to an increase in non-degraded ubiquitinated proteins that may enhance the ubiquitination activity of FBXO29 by increasing substrate availability.

Leupeptin hemisulfate

103476-89-7sc-295358
sc-295358A
sc-295358D
sc-295358E
sc-295358B
sc-295358C
5 mg
25 mg
50 mg
100 mg
500 mg
10 mg
$73.00
$148.00
$316.00
$499.00
$1427.00
$101.00
19
(3)

Leupeptin, an inhibitor of lysosomal proteases, can lead to the accumulation of proteins that are potential substrates for FBXO29, indirectly enhancing the ubiquitination activity of this protein.